CIK 0001111485 · Accelerated filer
RxSight, Inc.
Sign in to watch- Ticker
- RXST
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943268801
- Phone
- 949-521-7822
- Business address
- 100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
- Former names
- CALHOUN VISION INC
- 4 Grant or award Director acquired 2,554 shares (grant or award)
- 4 Grant or award Director acquired 2,554 shares (grant or award)
- 4 Grant or award Director acquired 2,554 shares (grant or award)
- 4 Grant or award Director acquired 2,554 shares (grant or award)
- 4 Open-market buy Director bought 5,000 shares at $61.09 ($305,457)
- 4 Option exercise Chief Operating Officer acquired 24,771 shares (option exercise)
- 4 Planned sale President & CEO sold 40,000 shares at $60.15 ($2,405,872)
- 4 Planned sale Chief Financial Officer sold 10,000 shares at an average $52.69 ($526,913)
- 4 Planned sale Chief Financial Officer sold 20,000 shares at an average $49.90 ($997,946)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Financial Officer sold 10,000 shares at an average $56.37 ($563,726)
- 4 Planned sale Chief Operating Officer sold 25,000 shares at an average $54.00 ($1,350,000)
- 4 Open-market buy Director bought 8,000 shares at an average $50.83 ($406,673)
- 4 Planned sale Chief Operating Officer sold 10,365 shares at an average $50.74 ($525,939)
- 4 Gift Director gave 53,967 shares (gift)
- 4 Open-market sale Chief Financial Officer sold 25,000 shares at an average $47.31 ($1,182,660)
- 4 Open-market sale Director sold 28,250 shares at an average $49.67 ($1,403,120)
Page 5 of 11 · 208 filings